LakeShore Biopharma Co., Ltd. (ticker: LSBCF) is an OTC-listed pharmaceutical preparations company. DredgeCap's structured extraction of LSBCF's SEC filings surfaces 3 active risk signals, including 1 auditor-change signal, 1 delisting/deregistration signal, and 1 late-filing signal. LSBCF reported $85.67M in revenue and -$13.93M for the period ending 2025-03-31, with operating cash flow of -$16.85M. Cash and equivalents stood at $3.91M (down 88.7% year-over-year). Total assets of $190.53M exceed total liabilities of $120.91M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
LSBCF Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for LakeShore Biopharma Co., Ltd. (LSBCF) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.